The impact of preoperative immunonutritional status on prognosis in ovarian cancer: a multicenter real-world study
- Xingyu Liu 1,2, Ming Li 3, Yingjun Zhao 3, Xiaofei Jiao 1,2, Yang Yu 1,2, Ruyuan Li 4, Shaoqing Zeng 1,2, Jianhua Chi 1,2, Guanchen Ma 1,2, Yabing Huo 1,2, Zikun Peng 1,2, Jiahao Liu 1,2, Qi Zhou 5,6,7, Dongling Zou 4,5,6, Li Wang 8, Qingshui Li 9, Jing Wang 10,11, Shuzhong Yao 12, Youguo Chen 13, Ding Ma 1,2, Ting Hu 14,15, Qinglei Gao 16,17
- Xingyu Liu 1,2, Ming Li 3, Yingjun Zhao 3
- 1Department of Gynecological Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- 2National Clinical Research Center for Obstetrics and Gynecology, Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Ave, Wuhan, 430000, China.
- 3Department of Gynaecology and Obstetrics, Henan Provincial People's Hospital, Henan, China.
- 4National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- 5Department of Gynecologic Oncology, Chongqing University Cancer Hospital, Chongqing, China.
- 6Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China.
- 7Key Laboratory for Biorheological Science and Technology of Ministry of Education (Chongqing University), Chongqing University Cancer Hospital, Chongqing, China.
- 8Department of Cancer Biology Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, Henan, China.
- 9Department of Gynecologic Oncology, Shandong Cancer Hospital and Institute, Jinan, Shandong, China.
- 10Hunan Clinical Research Center in Gynecologic Cancer, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Changsha, Hunan, China.
- 11Department of Gynecologic Cancer, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
- 12Department of Obstetrics and Gynecology, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China.
- 13Department of Gynecology & Obstetrics, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China.
- 14Department of Gynecological Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. tinghu_tj@163.com.
- 15National Clinical Research Center for Obstetrics and Gynecology, Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Ave, Wuhan, 430000, China. tinghu_tj@163.com.
- 16Department of Gynecological Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. qingleigao@hotmail.com.
- 17National Clinical Research Center for Obstetrics and Gynecology, Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Ave, Wuhan, 430000, China. qingleigao@hotmail.com.
- 0Department of Gynecological Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Poor preoperative immunonutritional status negatively impacts epithelial ovarian cancer prognosis. Optimizing nutritional and immune markers like the prognostic nutritional index (PNI) and systemic immune-inflammation index (SII) may improve patient survival outcomes.
Area Of Science
- Oncology
- Immunonutrition
- Cancer Prognostics
Background
- Epithelial ovarian cancer (EOC) prognosis is influenced by various patient factors.
- Preoperative immunonutritional status is increasingly recognized as a critical determinant of cancer outcomes.
Purpose Of The Study
- To evaluate the association between preoperative immunonutritional status and prognosis in epithelial ovarian cancer (EOC) patients.
- To determine the predictive value of the prognostic nutritional index (PNI) and systemic immune-inflammation index (SII) in EOC.
Main Methods
- A multicenter real-world study involving 922 EOC patients undergoing surgery.
- Assessment of immunonutritional status using Prognostic Nutritional Index (PNI) and Systemic Immune-Inflammation Index (SII).
- Cox regression analyses to identify prognostic factors for progression-free survival (PFS) and overall survival (OS).
Main Results
- In early-stage EOC, high PNI correlated with improved PFS and OS, while high SII was linked to worse PFS.
- In advanced-stage EOC, PNI and SII independently predicted overall survival (OS).
- Specific optimal cut-off values for PNI and SII were identified for both early and late-stage cohorts.
Conclusions
- Suboptimal preoperative immunonutritional status is detrimental to EOC patient prognosis.
- Interventions targeting immunonutritional status in EOC patients may enhance survival.
- PNI and SII serve as valuable indicators for predicting outcomes in EOC.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
01:27
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:21
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

